COR

Cencora, Inc.

NYSE · CIK 1140859

Last close309.05
Daily change-0.73 (-0.24%)
10 Years gain+327.06%
Dividends TTM2.4 (+9.09%)
Dividend yield0.77%

Fundamental Analysis

COR · STANDARD

SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Fiscal year end 0930

Screener
Fundamental
47.5
Momentum
50.9
Acceleration
30.6
Confidence
100.0
Annual Revenue19
Quarterly Revenue80
Annual CFO19
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth12.0 / 25
Quality10.5 / 25
Capital Efficiency10.8 / 20
Balance Sheet2.7 / 15
Shareholder Economics9.0 / 10
Forward Indicators0.0 / 5

Signals

Gross margin expansionGross margin improved by 0.4689 percentage points.
Operating leverageOperating margin improved by 0.1894 percentage points.
Share count reductionDiluted share count declined 0.5895%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.

Warnings

FCF deterioration · MEDIUMFree cash flow declined 37.5699%.
ROIC declining · MEDIUMROIC declined by 16.7784 percentage points.

Key Metrics

Revenue Growth TTM10.05%OK
Revenue CAGR 3Y10.43%OK
Gross Margin4%OK
Operating Margin1.18%OK
FCF Margin0.33%OK
FCF Growth-37.57%OK
ROIC32.24%OK
Incremental Operating Margin 3Y1.37%OK
Net Debt / CFO4.96xOK
Diluted Share Growth 1Y-0.59%OK
SBC / Revenue0.04%OK
SBC / FCF13.24%OK

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2025 FY Sep 30, 2025$321.33B$11.48B$2.63B$3.88B$3.21B3.57%0.82%1%54.36%195.21M
2025 FY Sep 30, 2024$293.96B$9.91B$2.18B$3.48B$3.00B3.37%0.74%1.02%71.41%200.28M
2025 FY Sep 30, 2023$262.17B$8.96B$2.34B$3.91B$3.45B3.42%0.89%1.32%77.87%204.59M
2024 FY Sep 30, 2022$238.59B$8.30B$2.37B$2.70B$2.21B3.48%0.99%0.92%55.9%211.21M
2023 FY Sep 30, 2021$213.99B$6.94B$2.35B$2.67B$2.23B3.24%1.1%1.04%114.33%208.47M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$329.71Bsum latest 4 fiscal quarters RevenueOK0001140859-26-000034, 0001140859-26-000006
Revenue Growth TTM10.05%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0001140859-26-000034, 0001140859-26-000006
Revenue CAGR 3Y10.43%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0001140859-25-000131
Revenue CAGR 5Y11.09%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0001140859-25-000131
Gross Profit CAGR 3Y11.43%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0001140859-25-000131
Operating Income Growth31.09%OperatingIncome_current / OperatingIncome_prior_year - 1OK0001140859-26-000034, 0001140859-26-000006
FCF Growth-37.57%FCF_current / FCF_prior_year - 1OK0001140859-26-000034, 0001140859-26-000020
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin4%Gross Profit / RevenueOK0001140859-26-000034, 0001140859-26-000006
Operating Margin1.18%Operating Income / RevenueOK0001140859-26-000034, 0001140859-26-000006
FCF Margin0.33%(CFO - CapEx) / RevenueOK0001140859-26-000034, 0001140859-26-000020
CFO / Net Income0.49xCFO / Net IncomeOK0001140859-26-000034, 0001140859-26-000020
FCF / Net Income0.3xFCF / Net IncomeOK0001140859-26-000034, 0001140859-26-000020
ROIC32.24%NOPAT / Average Invested CapitalOK0001140859-26-000034, 0001140859-26-000006
Net Debt / CFO4.96xNet Debt / CFOOK0001140859-26-000034, 0001140859-26-000020